CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
Senofilcon A contact lenses (TEST) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06161012
NCT06161012N/ACompleted
CompareCT.gov

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

Johnson & Johnson Vision Care, Inc.·interventional·Posted Dec 7, 2023·Updated Jun 22, 2025

In Brief

A clinical study evaluating Senofilcon A contact lenses (TEST) and Delefilcon A contact lenses (CONTROL) for Ocular Physiology. Completed, enrolled 67 participants across 6 sites.

Detailed Summary

This will be a multi-site, bilateral, dispensing, randomized, controlled, double-masked, 2×2 crossover study to evaluate ocular physiological response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOcular Physiology
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 7, 2023
Enrollment StartNov 16, 2023
Primary CompletionFeb 13, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.6 years ago

Interventions

Senofilcon A contact lenses (TEST)device

Rotationally stabilized astigmatic soft contact lenses in senofilcon A containing a chromophore to filter High-Energy Visible Light (HEVL)

Delefilcon A contact lenses (CONTROL)device

DAILIES TOTAL1® for Astigmatism Contact Lenses (DT1fA)